Tapcom-S Dosage/Direction for Use

Posology: Recommended therapy is one eye drop in the conjunctival sac of the affected eye(s) once daily.
If one dose is missed, treatment should continue with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily.
Tapcom-S is a preservative free sterile solution packaged in a single-dose container. For single use only, one container is sufficient to treat both eyes. Any unused solution should be discarded immediately after use.
Paediatric population: The safety and efficacy of Tapcom-S in children and adolescents below the age of 18 years have not been established. No data are available.
Tapcom-S is not recommended for use in children and adolescents below the age of 18 years.
Use in elderly: No dosage alteration in elderly patients is necessary.
Use in renal/hepatic impairment: Tafluprost and timolol eye drops have not been studied in patients with renal/hepatic impairment and Tapcom-S should therefore be used with caution in such patients.
Method of Administration: Ocular use.
To reduce the risk of darkening of the eyelid skin the patients should wipe off any excess solution from the skin.
When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase of local activity.
If more than one topical ophthalmic medicinal product is being used, each one should be administered at least 5 minutes apart.
Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes.
Patients should be instructed to avoid allowing the container to come into contact with the eye or surrounding structures as this could cause injury to the eye.
Patients should also be instructed that ocular solutions, if handled improperly, can become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.